Literature DB >> 8394065

Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica.

J Sanchez-Roman1, I Wichmann, J Salaberri, J M Varela, A Nuñez-Roldan.   

Abstract

OBJECTIVES: A self referred group of four workers from a factory producing scouring powder with a high silica content showed a surprisingly high number of features compatible with a connective tissue disease. Further subjects working at the same factory were subsequently studied to evaluate the relation between this exposure and the development of autoimmune processes.
METHODS: A total of 50 subjects (44 women, six men; mean (SD) age 43.7 (5.5) years; mean duration of employment 6.1 years) underwent a prospective study including clinical history and physical examination, an immunobiological study, HLA typing, radiological and functional oesophageal and respiratory examination, ophthalmological examination, and isotopic testing of salivary glands.
RESULTS: Symptoms of a systemic illness were present in 32 (64%) subjects: six with Sjögren's syndrome; five with the criteria for systemic sclerosis; three with systemic lupus erythematosus (SLE); five with an 'overlap syndrome'; and 13 with undifferentiated findings not meeting the criteria for a defined disease. Antinuclear antibodies were present in 36 (72%) subjects; four had antibodies to native DNA, including two subjects with SLE, one with systemic sclerosis associated with secondary Sjögren's syndrome, and one with overlap syndrome. Anticentromere antibodies were not detected. The frequency of HLA-DR3 was increased in the clinically affected subjects, but did not reach statistical significance.
CONCLUSIONS: This descriptive study emphasises the high probability of workers occupationally exposed to silica developing a multiple spectrum of clinical and serological autoimmune manifestations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394065      PMCID: PMC1005094          DOI: 10.1136/ard.52.7.534

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations.

Authors:  L D ERASMUS
Journal:  S Afr J Lab Clin Med       Date:  1957-09

2.  Circulating antinuclear antibody and rheumatoid factor in coal pneumoconiosis.

Authors:  C A Soutar; M Turner-Warwick; W R Parkes
Journal:  Br Med J       Date:  1974-07-20

Review 3.  Scleroderma and scleroderma-like disorders.

Authors:  V K Rocco; E R Hurd
Journal:  Semin Arthritis Rheum       Date:  1986-08       Impact factor: 5.532

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Some genetic aspects of systemic lupus erythematosus.

Authors:  R J Winchester; A Nunez-Roldan
Journal:  Arthritis Rheum       Date:  1982-07

6.  Silicosis due to intentional inhalation of abrasive scouring powder. Case report with long-term survival and vasculitic sequelae.

Authors:  H Gong; D P Tashkin
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

7.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Massive proteinuria and acute renal failure in a patient with acute silicoproteinosis.

Authors:  R D Giles; B C Sturgill; P M Suratt; W K Bolton
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

9.  [Pulmonary silicosis and disseminated lupus erythematosus].

Authors:  J Cledes; J P Hervé; J Clavier; P Youinou; J P Ollivier
Journal:  Poumon Coeur       Date:  1983

10.  The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis.

Authors:  G P Rodnan; T G Benedek; T A Medsger; R J Cammarata
Journal:  Ann Intern Med       Date:  1967-02       Impact factor: 25.391

View more
  30 in total

1.  Serum levels of soluble Fas ligand in patients with silicosis.

Authors:  A Tomokuni; T Otsuki; Y Isozaki; S Kita; H Ueki; M Kusaka; T Kishimoto; A Ueki
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Occupational exposure in patients with the antisynthetase syndrome.

Authors:  Ane Labirua-Iturburu; Albert Selva-O'Callaghan; Jan-Paul Zock; Ramon Orriols; Xavier Martínez-Gómez; Miquel Vilardell-Tarrés
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

3.  Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons.

Authors:  Samy Slimani; Amina Ben Ammar; Aicha Ladjouze-Rezig
Journal:  Clin Rheumatol       Date:  2010-01-28       Impact factor: 2.980

Review 4.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

5.  Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort.

Authors:  Luiza F Rocha; Ana Paula Luppino Assad; Roberta G Marangoni; Ana Paula Toledo Del Rio; João Francisco Marques-Neto; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2016-01-13       Impact factor: 2.631

6.  Rheumatological Diseases in Denim Sandblasters with Silicosis: What Should Pulmonologists Look for?

Authors:  Elif Altundaş Hatman; Duygu Acar Karagül; Zeki Kılıçaslan
Journal:  Turk Thorac J       Date:  2020-11-01

7.  Silicon nephropathy and myeloperoxidase antibodies.

Authors:  A Chevailler; F Carrere; G Renier; D Hurez; J F Subra; P Reboul; P Riberi; C Masson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

8.  End stage renal disease among ceramic workers exposed to silica.

Authors:  E Rapiti; A Sperati; M Miceli; F Forastiere; D Di Lallo; F Cavariani; D F Goldsmith; C A Perucci
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

9.  Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease.

Authors:  J F Subra; G Renier; P Reboul; F Tollis; R Boivinet; P Schwartz; A Chevailler
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

10.  Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours.

Authors:  A Tomokuni; T Aikoh; T Matsuki; Y Isozaki; T Otsuki; S Kita; H Ueki; M Kusaka; T Kishimoto; A Ueki
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.